Format
Sort by
Items per page

Send to

Choose Destination

Best matches for schizophrenia serotonin 1a receptor:

Search results

Items: 1 to 20 of 481

1.

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.

Marder S, Fleischhacker WW, Earley W, Lu K, Zhong Y, Németh G, Laszlovszky I, Szalai E, Durgam S.

Eur Neuropsychopharmacol. 2018 Nov 20. pii: S0924-977X(18)30843-5. doi: 10.1016/j.euroneuro.2018.10.008. [Epub ahead of print]

2.

Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.

Cao X, Zhang Y, Chen Y, Qiu Y, Yu M, Xu X, Liu X, Liu BF, Zhang L, Zhang G.

J Med Chem. 2018 Nov 21;61(22):10017-10039. doi: 10.1021/acs.jmedchem.8b01096. Epub 2018 Nov 9.

PMID:
30383372
3.

Involvement of 5-HT1A and 5-HT2A Receptors but Not α 2-Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain In Vivo.

Herman A, El Mansari M, Adham N, Kiss B, Farkas B, Blier P.

Mol Pharmacol. 2018 Dec;94(6):1363-1370. doi: 10.1124/mol.118.113290. Epub 2018 Oct 15.

PMID:
30322874
4.

Aripiprazole: An FDA Approved Bioactive Compound to treat schizophrenia-A Mini Review.

Kumar A, Singh H, Mishra A, Mishra AK.

Curr Drug Discov Technol. 2018 Oct 8. doi: 10.2174/1570163815666181008151718. [Epub ahead of print]

PMID:
30306873
5.

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole.

Osuna-Luque J, Rodríguez-Ramos Á, Gámez-Del-Estal MDM, Ruiz-Rubio M.

J Exp Neurosci. 2018 Sep 18;12:1179069518798628. doi: 10.1177/1179069518798628. eCollection 2018.

6.

Other Antidepressants.

Schwasinger-Schmidt TE, Macaluso M.

Handb Exp Pharmacol. 2018 Sep 8. doi: 10.1007/164_2018_167. [Epub ahead of print]

PMID:
30194544
7.

Cav1.2 L-type calcium channels regulate stress coping behavior via serotonin neurons.

Ehlinger DG, Commons KG.

Neuropharmacology. 2019 Jan;144:282-290. doi: 10.1016/j.neuropharm.2018.08.033. Epub 2018 Sep 1.

PMID:
30176250
8.

Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes.

Choi YK, Tarazi FI.

J Mol Neurosci. 2018 Sep;66(1):59-67. doi: 10.1007/s12031-018-1133-z. Epub 2018 Aug 9.

PMID:
30091081
9.

The affinity of antipsychotic drugs to dopamine and serotonin 5-HT2 receptors determines their effects on prefrontal-striatal functional connectivity.

Tollens F, Gass N, Becker R, Schwarz AJ, Risterucci C, Künnecke B, Lebhardt P, Reinwald J, Sack M, Weber-Fahr W, Meyer-Lindenberg A, Sartorius A.

Eur Neuropsychopharmacol. 2018 Sep;28(9):1035-1046. doi: 10.1016/j.euroneuro.2018.05.016. Epub 2018 Jul 10.

PMID:
30006253
10.

Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P.

Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. Review.

PMID:
29789034
11.

The preclinical discovery and development of cariprazine for the treatment of schizophrenia.

Wesołowska A, Partyka A, Jastrzębska-Więsek M, Kołaczkowski M.

Expert Opin Drug Discov. 2018 Aug;13(8):779-790. doi: 10.1080/17460441.2018.1471057. Epub 2018 May 3.

PMID:
29722587
12.

In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug.

Xu Y, Zhu X, Wang H, Sun S, Yue X, Tian J.

Sci Rep. 2018 May 2;8(1):6892. doi: 10.1038/s41598-018-25036-0.

13.

Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia.

Mohammadi A, Rashidi E, Amooeian VG.

Psychiatry Res. 2018 Jul;265:25-38. doi: 10.1016/j.psychres.2018.04.036. Epub 2018 Apr 13. Review.

PMID:
29680514
14.

Repeated Clozapine Increases the Level of Serotonin 5-HT1AR Heterodimerization with 5-HT2A or Dopamine D2 Receptors in the Mouse Cortex.

Szlachta M, Kuśmider M, Pabian P, Solich J, Kolasa M, Żurawek D, Dziedzicka-Wasylewska M, Faron-Górecka A.

Front Mol Neurosci. 2018 Feb 15;11:40. doi: 10.3389/fnmol.2018.00040. eCollection 2018.

15.

Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms.

Huang X, Yang J, Yang S, Cao S, Qin D, Zhou Y, Li X, Ye Y, Wu J.

Oncotarget. 2017 Oct 27;8(60):102705-102720. doi: 10.18632/oncotarget.22170. eCollection 2017 Nov 24. Review.

16.

Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.

Zheng W, Li XH, Cai DB, Yang XH, Ungvari GS, Ng CH, Ning YP, Xiang YT.

Eur Neuropsychopharmacol. 2018 Jan;28(1):149-158. doi: 10.1016/j.euroneuro.2017.11.007. Epub 2017 Nov 22.

PMID:
29174529
17.

Aripiprazole in treatment of Gilles de la Tourette syndrome - New therapeutic option.

Janik P, Szejko N.

Neurol Neurochir Pol. 2018 Jan - Feb;52(1):84-87. doi: 10.1016/j.pjnns.2017.10.015. Epub 2017 Nov 9. Review.

PMID:
29154107
18.

The antipsychotic-like effects in rodents of YQA31 involve dopamine D3 and 5-HT1A receptor.

Gou HY, Sun X, Li F, Wang ZY, Wu N, Su RB, Cong B, Li J.

Pharmacol Rep. 2017 Dec;69(6):1125-1130. doi: 10.1016/j.pharep.2017.05.007. Epub 2017 May 24.

PMID:
29128790
19.

The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks.

van den Munkhof HE, Arnt J, Celada P, Artigas F.

Eur Neuropsychopharmacol. 2017 Dec;27(12):1248-1257. doi: 10.1016/j.euroneuro.2017.10.034. Epub 2017 Nov 8.

PMID:
29128144
20.

Regulation of Hippocampal 5-HT Release by P2X7 Receptors in Response to Optogenetic Stimulation of Median Raphe Terminals of Mice.

Gölöncsér F, Baranyi M, Balázsfi D, Demeter K, Haller J, Freund TFF, Zelena D, Sperlágh B.

Front Mol Neurosci. 2017 Oct 12;10:325. doi: 10.3389/fnmol.2017.00325. eCollection 2017.

Supplemental Content

Loading ...
Support Center